Quince Therapeutics Statistics

Total Valuation

QNCX has a market cap or net worth of $15.38 million. The enterprise value is -$2.38 million.

Market Cap	15.38M
Enterprise Value	-2.38M

Important Dates

The next estimated earnings date is Monday, August 10, 2026, after market close.

Earnings Date	Aug 10, 2026
Ex-Dividend Date	n/a

Share Statistics

QNCX has 16.30 million shares outstanding. The number of shares has increased by 42.34% in one year.

Current Share Class	16.30M
Shares Outstanding	16.30M
Shares Change (YoY)	+42.34%
Shares Change (QoQ)	+65.04%
Owned by Insiders (%)	3.63%
Owned by Institutions (%)	8.27%
Float	14.30M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.83
P/TBV Ratio	0.98
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.92, with a Debt / Equity ratio of 0.03.

Current Ratio	2.92
Quick Ratio	2.82
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-53.18

Financial Efficiency

Return on equity (ROE) is -192.90% and return on invested capital (ROIC) is -120.53%.

Return on Equity (ROE)	-192.90%
Return on Assets (ROA)	-45.44%
Return on Invested Capital (ROIC)	-120.53%
Return on Capital Employed (ROCE)	-272.23%
Weighted Average Cost of Capital (WACC)	16.07%
Revenue Per Employee	n/a
Profits Per Employee	-$951,447
Employee Count	38
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-2.17M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -94.10% in the last 52 weeks. The beta is 1.37, so QNCX's price volatility has been higher than the market average.

Beta (5Y)	1.37
52-Week Price Change	-94.10%
50-Day Moving Average	1.13
200-Day Moving Average	12.67
Relative Strength Index (RSI)	41.42
Average Volume (20 Days)	491,588

Short Selling Information

The latest short interest is 2.01 million, so 12.35% of the outstanding shares have been sold short.

Short Interest	2.01M
Short Previous Month	2.06M
Short % of Shares Out	12.35%
Short % of Float	14.07%
Short Ratio (days to cover)	1.04

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-48.61M
Pretax Income	-35.21M
Net Income	-36.16M
EBITDA	-48.46M
EBIT	-48.61M
Earnings Per Share (EPS)	-$6.86

Full Income Statement

Balance Sheet

The company has $18.16 million in cash and $406,000 in debt, giving a net cash position of $17.76 million or $1.09 per share.

Cash & Cash Equivalents	18.16M
Total Debt	406,000
Net Cash	17.76M
Net Cash Per Share	$1.09
Equity (Book Value)	15.67M
Book Value Per Share	1.14
Working Capital	16.81M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$39.45 million and capital expenditures -$204,000, giving a free cash flow of -$39.66 million.

Operating Cash Flow	-39.45M
Capital Expenditures	-204,000
Depreciation & Amortization	146,000
Net Borrowing	-5.55M
Free Cash Flow	-39.66M
FCF Per Share	-$2.43

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

QNCX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-42.34%
Shareholder Yield	-42.34%
Earnings Yield	-235.08%
FCF Yield	-257.84%

Analyst Forecast

The average price target for QNCX is $4.00, which is 323.95% higher than the current price. The consensus rating is "Buy".

Price Target	$4.00
Price Target Difference	323.95%
Analyst Consensus	Buy
Analyst Count	5
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on April 13, 2026. It was a reverse split with a ratio of 1:10.

Last Split Date	Apr 13, 2026
Split Type	Reverse
Split Ratio	1:10

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a